Health Care Equipment & Services

CTO’s strategic buy‑back fuels optimism for Innovative Eyewear despite volatile share price and mixed insider trades.

Accuray insider activity shows a strategic shift: executives sell vested RSUs for liquidity while keeping common shares, signaling confidence in a turnaround.

Insightful insider buying by Innovative Eyewear’s top execs shows confidence amid volatility—watch their moves to gauge future upside.

Joshua Levine’s 25,000‑share holding in EDAP TMS SA signals board confidence, suggesting the stock is still undervalued amid its recent rally.

Insider buying by Edwards Lifesciences’ chief valuation pro signals confidence amid a near 52‑week high and potential JenaValve deal, boosting investor optimism.

Insider filings show Stryker’s leaders hold steady, reflecting confidence and disciplined equity strategy amid strong fundamentals and future growth plans.

Chacon Quiros Juan Jose’s August 2025 share purchase and new equity award at Establishment Labs signals insider confidence amid price‑earnings concerns and a 52‑week low, urging investors to weigh long‑term gains against current risks.

Garipalli Vivek’s latest Clover Health share purchase signals insider confidence, revealing why top shareholders buy during vesting and what it means for investors.

Butterfly Network CFO’s 60k‑share sell‑to‑cover at $3.98 shows a routine tax‑cover move, not a warning; investors can see it as normal liquidity and still focus on the company’s growth.

CEO Siokas Grigorios’s latest buy at Cosmos Health shows bullish confidence while a debt‑to‑equity swap strengthens the balance sheet—what’s next for the stock?